Published in Clin Exp Immunol on September 01, 1969
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
T and B lymphocytes in New Zealand black mice. An analysis of the theta, TL and MBLA markers. Clin Exp Immunol (1972) 1.03
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology (1962) 6.24
Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med (1966) 4.19
[STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM]. J Reticuloendothel Soc (1964) 3.93
Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med (1969) 2.78
Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med (1967) 2.53
TOLERANCE TO A PROTEIN ANTIGEN IN ADULT MICE AND THE EFFECT OF NONSPECIFIC FACTORS. J Immunol (1963) 2.31
Autoimmune reactions and virus-like particles in germ-free NZB mice. Lancet (1967) 1.88
Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol (1967) 1.85
Antigenicity in mice of antilymphocyte gamma-globulin. Nature (1967) 1.67
Immune response to a soluble protein antigen in NZB mice. Nature (1968) 1.51
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46
Rapid loss of tolerance induced in weanling NZB and B-W F1 mice. Science (1969) 1.16
Autoimmunity and malignancy in New Zealand black mice. Proc R Soc Med (1967) 1.13
Comparative immunogenicity of antilymphocytic globulin in solution and adsorbed on lymphocytes. Nature (1968) 0.92
[Presence of viral particles in the organs of the NZB mouse]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.92
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
The whiplash syndrome--common sense revisited. J Rheumatol (1997) 7.20
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
The use of standardized patients in the performance of a needs assessment and development of a CME intervention in rheumatology for primary care physicians. J Rheumatol (1997) 2.67
Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study. J Rheumatol (1999) 2.45
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Osteoporosis follow-up after wrist fractures following minor trauma. Arch Intern Med (2001) 2.36
Serum transaminases during salicylate therapy. Br Med J (1971) 2.34
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
The genetics of psoriasis. Haplotype sharing in siblings with the disease. Arch Dermatol (1990) 2.12
Septic arthritis. Ann Rheum Dis (1972) 2.06
Development of persistent neurologic symptoms in patients with simple neck sprain. Arthritis Care Res (1999) 2.05
Alternative therapies--medicine, magic, or quackery. Who is winning the battle? J Rheumatol (1997) 2.00
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol (2001) 1.93
Use of lumbar radiographs for the early diagnosis of low back pain. Proposed guidelines would increase utilization. JAMA (1997) 1.92
Cell-mediated immunity to herpes simplex virus in man. J Infect Dis (1974) 1.91
Lack of congruence in the ratings of patients' health status by patients and their physicians. Med Decis Making (2001) 1.75
Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol (1992) 1.69
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J Rheumatol (1995) 1.62
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol (1996) 1.60
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol (1992) 1.56
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis. Ann Rheum Dis (1978) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells. Infect Immun (1975) 1.43
Performance of online biomedical databases in rheumatology. J Rheumatol (1994) 1.42
The art versus the science of medicine. Are clinical practice guidelines the answer? Ann Rheum Dis (1998) 1.40
Combination drug therapy in rheumatoid arthritis. J Rheumatol (1997) 1.40
Generic health instruments do not comprehensively capture patient perceived improvement in patients with carpal tunnel syndrome. J Rheumatol (1999) 1.39
HLA-B27 and arthritis: back to the future. Part I. J Rheumatol (1991) 1.39
The effect of in vivo and in vitro methotrexate on lymphocyte proliferation as measured by the uptake of tritiated thymidine and tritiated guanosine. Clin Exp Rheumatol (1989) 1.38
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol (1999) 1.36
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis (1977) 1.32
Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants. CMAJ (1996) 1.28
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003). Ann Rheum Dis (2003) 1.25
Symptom expectation after minor head injury. A comparative study between Canada and Lithuania. Clin Neurol Neurosurg (2001) 1.21
Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol (1988) 1.20
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
Scintigraphic findings in ankylosing spondylitis. J Nucl Med (1977) 1.16
Scintigraphy of sacroiliac joints in acute anterior uveitis. A study of thirty patients. Ann Intern Med (1976) 1.16
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Investigation of sacroiliac disease: Comparative evaluation of radiological and radionuclide techniques. J Rheumatol (1975) 1.13
Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum (2001) 1.13
A rapid and sensitive assay for arginase. Anal Biochem (1980) 1.13
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
The scintigraphic investigation of sacroiliac disease. J Nucl Med (1977) 1.12
Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: results of a controlled trial. Osteoporos Int (2006) 1.12
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Cell-mediated immunity to herpes simplex virus in man. Am J Clin Pathol (1973) 1.10
Stereoselective pharmacokinetics of flurbiprofen in humans and rats. J Pharm Sci (1988) 1.10
Management of rheumatoid arthritis: the historical context. J Rheumatol (2001) 1.09
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol (1989) 1.09
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
A re-examination of the whiplash associated disorders (WAD) as a systemic illness. Ann Rheum Dis (2005) 1.08
Neck injury and chronic pain syndromes: comment on the article by Buskila et al. Arthritis Rheum (1998) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol (1977) 1.07
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
HL-A (transplantation) antigens in ankylosing spondylitis and Crohn's disease. J Rheumatol (1974) 1.06
Antimalarials in rheumatology: efficacy and safety. Semin Arthritis Rheum (1987) 1.06
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol (2001) 1.05
Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol (2001) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
The best approach to the problem of whiplash? One ticket to Lithuania, please. Clin Exp Rheumatol (1999) 1.03
Transplantation antigens in Crohn's disease: Linkage of associated ankylosing spondylitis with HL-Aw27. Am J Dig Dis (1975) 1.03
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol (1984) 1.02
Long-term effectiveness of antimalarial drugs in rheumatic diseases. Ann Rheum Dis (1998) 1.01
Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness. J Rheumatol (1995) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
A possible role for polymorphonuclear leucocytes in the defence against recrudescent herpes simplex virus infection in man. Immunology (1978) 1.01
Immunologic and inflammatory responses during pregnancy. J Clin Lab Immunol (1984) 1.00
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Epidemiology of whiplash: an international dilemma. Ann Rheum Dis (1999) 0.99
Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis (1998) 0.98